Global Nerve Repair and Regeneration Market: By Product (Biomaterials, Neurostimulation and Neuromodulation Devices), By Application (Stem Cell Therapy, Nerve Grafting, Neurostimulation and Neuromodulation Surgeries, Direct Nerve Repair/ Neurorrhaphy), By End User (Hospitals, Ambulatory Surgery Center, Others), and Geography    

Nerve Repair & Regeneration Market

Global Nerve Repair and Regeneration Market was valued at US $ XX Mn and expected to grow at 14.3% Compound Annual Growth Rate (CAGR) over the 2020 to 2026.

  Market Outline: 

Nerve repair and regeneration refers to the repair and regeneration of the nervous tissues or cells. The regeneration of the neurons differs between peripheral nervous system (PNS) and the central nervous system (CNS) by the functional mechanisms.

  Market Dynamics: 

Increase in the prevalence of neurological & epidemic disorders are the key factors driving the growth of the nerve repair and regeneration market. Rising geriatric population along with increasing health issues is anticipating the growth of the market. According to American Geriatrics Society (AGS), around 20.0% of Americans are expected to be more than 65 years of age by 2030, and 21.0% of those over 60 years of age are likely to undergo surgical procedures. Technological advancements are adding fuel for the growth of the market. Lack od awareness among the people regarding the nerve repair and regeneration products and techniques are boosting the growth of the market. Various CNS disorders such as Parkinson’s disease and Alzheimer’s disease are enhancing the growth of the Nerve repair and regeneration market. The presence of alternative techniques is hindering the growth of the market. The high cost of the treatment is hampering the growth of the nerve repair and regeneration market.

  Market Scope:  Nerve repair and regeneration market is segmented based on the product, application, and end user Based on the product, the market is segmented into the following:

• Biomaterials
  • Nerve Wraps
  • Nerve Connectors
  • Nerve Conduit
  • Nerve Protectors
• Neurostimulation and Neuromodulation Devices
  • Internal Neurostimulation Devices
    • Vagus Nerve Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation
    • Spinal Cord Stimulation
    • Deep Brain Stimulation

Based on the application, the market is segmented into the following:

• Stem Cell Therapy
• Nerve Grafting
  • Autograft
  • Allograft
  • Xenograft
• Neurostimulation and Neuromodulation Surgeries
  • Internal Neurostimulation and Neuromodulation Surgeries
  • External Neurostimulation and Neuromodulation Surgeries
• Direct Nerve Repair/ Neurorrhaphy
  • Epineural Repair
  • Perineural Repair
  • Group Fascicular Repair

Based on the end user, the market is segmented into the following:

• Hospitals
• Ambulatory Surgery Center
• Others

    Regional Analysis:  

Geographically, global nerve repair and regeneration market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America nerve repair and regeneration market is growing due to increase in the prevalence of Alzheimer’s disease. According to the Centers for Disease Control and prevention (CDC), 5 million Americans are estimated to be living with Alzheimer’s disease. The death rate due to Alzheimer’s disease has increased 55% from 1999 to 2014. In 2014, over 93,500 deaths across all 50 states and the District of Columbia occurred due to Alzheimer’s disease. Europe and the Asia Pacific nerve repair and regeneration market are expected to propel over the forecasted period owing to the developing healthcare infrastructure. The Asia Pacific nerve repair and regeneration market is expected to grow at fast pace due to the presence of emerging economies and rising population with rising nerve disorders.

    Competition Assessment:  Some of the players in the global nerve repair and regeneration market include:

• AxoGen Inc. (U.S.)
• Baxter International (U.S.)
• Medtronic (US)
• Cyberonics Inc. (U.S.)
• Integra Lifesciences Corporation (U.S.)
• Boston Scientific (US)
• Abbott Laboratories (US)
• LivaNova (UK)
• Baxter (US)
• AxoGen (US)
• Stryker (US)

  Notable Market Developments: 

• In October 2017, LivaNova has receives FDA approval for SenTiva Device

 

---

Location

GEOGRAPHY